Skip to main content

ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge.

Publication ,  Journal Article
Sweitzer, MM; Kollins, SH; Kozink, RV; Hallyburton, M; English, J; Addicott, MA; Oliver, JA; McClernon, FJ
Published in: Neuropsychopharmacology
March 2018

Smoking withdrawal negatively impacts inhibitory control, and these effects are greater for smokers with preexisting attention problems, such as attention deficit/hyperactivity disorder (ADHD). The current study preliminarily evaluated changes in inhibitory control-related behavior and brain activation during smoking withdrawal among smokers with ADHD. Moreover, we investigated the role of catecholamine transmission in these changes by examining the effects of 40 mg methylphenidate (MPH) administration. Adult daily smokers with (n=17) and without (n=20) ADHD completed fMRI scanning under each of three conditions: (a) smoking as usual+placebo; (b) 24 h smoking abstinence+placebo and (c) 24 h smoking abstinence+MPH. Scan order was randomized and counterbalanced. Participants completed a modified Go/No-Go task to assess both sustained and transient inhibitory control. Voxelwise analysis of task-related BOLD signal revealed a significant group-by-abstinence interaction in occipital/parietal cortex during sustained inhibition, with greater abstinence-induced decreases in activation observed among ADHD smokers compared with non-ADHD smokers. Changes in behavioral performance during abstinence were associated with changes in activation in regions of occipital and parietal cortex and bilateral insula during sustained inhibition in both groups. MPH administration improved behavioral performance and increased sustained inhibitory control-related activation for both groups. During transient inhibition, MPH increased prefrontal activation for both groups and increased striatal activation only among ADHD smokers. These preliminary findings suggest that abstinence-induced changes in catecholamine transmission in visual attention areas (eg, occipital and superior parietal cortex) may be associated with inhibitory control deficits and contribute to smoking vulnerability among individuals with ADHD.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Neuropsychopharmacology

DOI

EISSN

1740-634X

Publication Date

March 2018

Volume

43

Issue

4

Start / End Page

851 / 858

Location

England

Related Subject Headings

  • Young Adult
  • Substance Withdrawal Syndrome
  • Smoking Cessation
  • Smoking
  • Psychomotor Performance
  • Psychiatry
  • Photic Stimulation
  • Neuroimaging
  • Methylphenidate
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sweitzer, M. M., Kollins, S. H., Kozink, R. V., Hallyburton, M., English, J., Addicott, M. A., … McClernon, F. J. (2018). ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge. Neuropsychopharmacology, 43(4), 851–858. https://doi.org/10.1038/npp.2017.248
Sweitzer, Maggie M., Scott H. Kollins, Rachel V. Kozink, Matt Hallyburton, Joseph English, Merideth A. Addicott, Jason A. Oliver, and F Joseph McClernon. “ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge.Neuropsychopharmacology 43, no. 4 (March 2018): 851–58. https://doi.org/10.1038/npp.2017.248.
Sweitzer MM, Kollins SH, Kozink RV, Hallyburton M, English J, Addicott MA, et al. ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge. Neuropsychopharmacology. 2018 Mar;43(4):851–8.
Sweitzer, Maggie M., et al. “ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge.Neuropsychopharmacology, vol. 43, no. 4, Mar. 2018, pp. 851–58. Pubmed, doi:10.1038/npp.2017.248.
Sweitzer MM, Kollins SH, Kozink RV, Hallyburton M, English J, Addicott MA, Oliver JA, McClernon FJ. ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge. Neuropsychopharmacology. 2018 Mar;43(4):851–858.

Published In

Neuropsychopharmacology

DOI

EISSN

1740-634X

Publication Date

March 2018

Volume

43

Issue

4

Start / End Page

851 / 858

Location

England

Related Subject Headings

  • Young Adult
  • Substance Withdrawal Syndrome
  • Smoking Cessation
  • Smoking
  • Psychomotor Performance
  • Psychiatry
  • Photic Stimulation
  • Neuroimaging
  • Methylphenidate
  • Male